We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 390

Death of the 'starting point' approach: AstraZeneca v Apotex

  • Shelston IP
  • -
  • Australia
  • -
  • October 29 2014

A recent decision of the Full Court of the Federal Court of Australia, AstraZeneca AB v Apotex Pty Ltd (2014) 312 ALR 1 ('AstraZeneca') has clarified

Agribusiness innovation catches rival going over the wall

  • Allens
  • -
  • Australia
  • -
  • October 28 2014

There is a misconception that a patent can be circumvented by a modification of a product by 10 per cent or 20 per cent. In reality, if the wording

Journal 2014 July to September for Australian readers

  • Watermark Patent & Trade Marks Attorneys
  • -
  • Australia
  • -
  • October 22 2014

The controversial issue of gene patenting has hit the headlines, yet again, following the recent Full Federal Court of Australia (‘FFCA’) decision in

Federal Court of Australia declined to follow U.S. Supreme Court in Myriad

  • Brinks Gilson & Lione
  • -
  • Australia, USA
  • -
  • October 21 2014

Recently, the Federal Court of Australia found that isolated DNA is patent eligible, contrary to the holding in Ass'n for Molecular Pathology v

Australian Patent Office flexes re-examination muscle

  • Phillips Ormonde Fitzpatrick
  • -
  • Australia
  • -
  • October 9 2014

In the decision of Huping Hu (2014) APO 17, the Australian Patent Office has re examined a granted patent via the new re examination provisions

The BRCA1 case: a Myriad of possibilities

  • ENSafrica
  • -
  • Australia, USA
  • -
  • October 7 2014

In an interesting development, contrary to the finding of the US Supreme Court in a similar case in the United States, the Australian Federal Court

Construing relative terms in Australian patent claims: when expert evidence does not assist

  • Houlihan2
  • -
  • Australia
  • -
  • October 6 2014

In a recent decision, Fei Yu trading as Jewels 4 Pools v Beadcrete Pty Ltd 2014, the Federal Court of Australia dismissed an appeal by Fei Yu

Have the courts lowered the bar on inventive step?

  • Freehills Patent Attorneys
  • -
  • Australia
  • -
  • October 2 2014

An appeal was brought before the Full Federal Court to consider, inter alia, the starting point for inventive step

Full Federal Court confirms isolated genes to remain patent eligible in Australia

  • Baldwins
  • -
  • Australia
  • -
  • September 30 2014

This month we continue our coverage of the ongoing dispute before the Australian Courts to determine the patent eligibility of isolated human genetic

Isolated genetic material remains patentable in Australia

  • Henry Hughes
  • -
  • Australia
  • -
  • September 24 2014

The Full Federal Court of Australia has confirmed in a unanimous decision of 5 judges that isolated genetic material is patentable subject matter in